Ge Healthcare Technologies Inc Revenue Growth Rates (GEHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

GEHC's Revenue Growth by Quarter and Year

Ge Healthcare Technologies Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GEHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 4,260.00
FY 4,260.00





GEHC Revenue first quarter 2026 Y/Y Growth Comment
Ge Healthcare Technologies Inc achieved in the first quarter 2026, above Company average Revenue improvement of 7.17% year on year, to $ 4,260.00 millions.

Looking into first quarter 2026 results within Medical Laboratories industry 21 other companies have achieved higher Revenue growth. While Ge Healthcare Technologies Inc ' s Revenue increase of 7.17% ranks overall at the positon no. 2158 in the first quarter 2026.


GEHC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 6.87 % 1.74 % -10.41 %
3rd Quarter September - 4.95 % 1.2 % -12.35 %
2nd Quarter June - 2.42 % 0.57 % -10.26 %
1st Quarter March 7.17 % 2.74 % -1.5 % -9.56 %
FY   - 4.33 % 0.54 % -

Financial Statements
Ge Healthcare Technologies Inc 's first quarter 2026 Revenue $ 4,260.00 millions GEHC's Income Statement
Ge Healthcare Technologies Inc 's first quarter 2025 Revenue $ 3,975.00 millions Quarterly GEHC's Income Statement


GEHC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 12.91 % 10.89 % 10.3 %
3rd Quarter September - 2.77 % 0.3 % -0.32 %
2nd Quarter June - 4.28 % 4.6 % 2.44 %
1st Quarter March -11.43 % -11.69 % -12.55 % -20.45 %
FY (Year on Year)   - 4.33 % 0.54 % -


Back to GEHC Growth rate Comparisons >> Back to GEHC Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #324
Overall #2158

Revenue Y/Y Growth Statistics
High Average Low
5.39 % 2.79 % 0.54 %
(Mar 31 2026)   (Dec 31 2024)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #324
Overall #2158
Revenue Y/Y Growth Statistics
High Average Low
5.39 % 2.79 % 0.54 %
(Mar 31 2026)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Ge Healthcare Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
12.91 % 1.04 % -12.55 %
(Dec 31 2025)  


GEHC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Ge Healthcare Technologies Inc disclosed drop in Revenue from the fourth quarter by -11.43% to $ 4,260.00 millions, from $ 4,810.00 millions achived in the previous reporting period.

But that's not important problem, as Ge Healthcare Technologies Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Laboratories industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Ge Healthcare Technologies Inc 's Revenue growth quarter on quarter, overall rank is 2546.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #25
Healthcare Sector #328
Overall #2546
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #25
Healthcare Sector #328
Overall #2546
Revenue Q/Q Growth Statistics
High Average Low
12.91 % 1.04 % -12.55 %
(Dec 31 2025)  


GEHC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Ge Healthcare Technologies Inc disclosed drop in Revenue from the fourth quarter by -11.43% to $ 4,260.00 millions, from $ 4,810.00 millions achived in the previous reporting period.

But that's not important problem, as Ge Healthcare Technologies Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Laboratories industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Ge Healthcare Technologies Inc 's Revenue growth quarter on quarter, overall rank is 2546.


Ge Healthcare Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 17,475.00 $ 17,190.00 $ 16,881.00 $ 16,680.00 $ 16,582.00
Y / Y Revenue Growth (TTM) 5.39 % 4.33 % 2.94 % 2.01 % 1.56 %
Year on Year Revenue Growth Overall Ranking # 2195 # 280 # 332 # 689 # 663
Seqeuential Revenue Change (TTM) 1.66 % 1.83 % 1.21 % 0.59 % 0.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 2365 # 280 # 334 # 709 # 2159


Cumulative Revenue growth Comment
With 5.39% annual Revenue growth, Ge Healthcare Technologies Inc would report a record annual Revenue improvement if the fiscal year would end on Mar 31 2026.

In the Healthcare sector 316 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 280 to 2195.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 317
Overall # 2195

Revenue TTM Y/Y Growth Statistics
High Average Low
5.39 %
 2.79 %
0.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 348
S&P 500 # 2365
Cumulative Revenue growth Comment
With 5.39% annual Revenue growth, Ge Healthcare Technologies Inc would report a record annual Revenue improvement if the fiscal year would end on Mar 31 2026.

In the Healthcare sector 316 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 280 to 2195.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 317
Overall # 2195

Revenue TTM Y/Y Growth Statistics
High Average Low
5.39 %
2.79 %
0.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 348
S&P 500 # 2365




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GEHC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Dbv Technologies S a 12.50%$ 12.500 millions
Abbvie Inc 12.43%$ 12.433 millions
Novocure Limited12.30%$ 12.298 millions
Lemaitre Vascular Inc 11.74%$ 11.740 millions
Bausch Health Companies Inc 11.73%$ 11.731 millions
Orthopediatrics Corp11.73%$ 11.726 millions
Innoviva Inc 11.71%$ 11.705 millions
Boston Scientific Corporation11.60%$ 11.602 millions
Keenova Therapeutics Plc11.36%$ 11.360 millions
Aclarion Inc 11.32%$ 11.316 millions
Si bone inc 11.24%$ 11.241 millions
Pacs Group Inc 11.22%$ 11.224 millions
Sight Sciences Inc 11.02%$ 11.021 millions
Ss Innovations International Inc11.01%$ 11.010 millions
Royalty Pharma Plc10.97%$ 10.969 millions
Resmed Inc 10.87%$ 10.875 millions
Medline Inc 10.66%$ 10.656 millions
Rigel Pharmaceuticals Inc10.28%$ 10.284 millions
Msa Safety Inc10.27%$ 10.273 millions
Phibro Animal Health Corporation10.10%$ 10.101 millions
Johnson and Johnson9.91%$ 9.907 millions
Acadia Pharmaceuticals Inc 9.72%$ 9.719 millions
Sotera Health Company9.68%$ 9.683 millions
Universal Health Services Inc 9.65%$ 9.646 millions
Earth Science Tech Inc 9.46%$ 9.462 millions
Bausch and Lomb Corp9.41%$ 9.411 millions
Zimmer Biomet Holdings Inc 9.30%$ 9.303 millions
Avanos Medical Inc 9.23%$ 9.233 millions
Quest Diagnostics Inc9.16%$ 9.163 millions
Encompass Health Corporation9.01%$ 9.015 millions


About Ge Healthcare Technologies Inc Revenue Growth Rates (GEHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Ge Healthcare Technologies Inc (CIK 1932393).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001932393-26-000046
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Ge Healthcare Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.